Karus Therapeutics
2 Venture Road
Southampton Science Park
Chilworth
Hampshire
SO16 7NP
United Kingdom
Website: http://www.karustherapeutics.com/
11 articles about Karus Therapeutics
-
Karus Therapeutics to Announce Positive New Data from Phase I Relapsed/Refractory B-Cell Lymphoma Trial at ASH
12/4/2019
Karus Therapeutics Ltd, a clinical-stage biopharmaceutical company developing precision medicines for cancer, announces that new data will be presented from its KA2237 Phase I study at the ASH Annual Meeting & Exposition in Orlando, Florida, 9 December 2019.
-
BioSpace Movers and Shakers, July 19
7/19/2019
Pharma and biotech companies from across the globe expand their leadership teams and boards. -
Karus Therapeutics Strengthens Clinical Leadership Team with Appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer
7/17/2019
Karus Therapeutics Ltd, a clinical-stage biopharmaceutical company developing precision medicines for cancer, announced the appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer with immediate effect.
-
Karus Therapeutics Announces First Cancer Patients Dosed With KA2507, A Small Molecule HDAC6-Selective Inhibitor, In A Phase I Clinical Trial
9/18/2017
-
Karus Therapeutics Announces First Lymphoma Patients Dosed With KA2237 In Clinical Study At MD Anderson Cancer Center
10/5/2016
-
Karus Therapeutics Announces Strategic Collaboration With University of Texas MD Anderson Cancer Center
12/10/2015
-
Karus Therapeutics Appoints New Head Of Clinical Development And Head Of Biology
10/21/2014
-
Karus Therapeutics Appoints Penelope Ward as CMO
11/12/2013
-
Karus Therapeutics Appoints Scientific Advisory Board and Announces Move to New Oxford Facilities
4/9/2013
-
Karus Therapeutics Announces Collaboration With Babraham Institute to Explore PI3 Kinase Inhibitors in the Treatment of Inflammatory Diseases
12/13/2012
-
Karus Therapeutics $7.6 Million Series B Financing
9/6/2012